EVOLENT HEALTH INC - NOTE 2.000%12/0

CUSIP: 30050BAB7

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Debt / NOTE 2.000%12/0
Market price (% of par)
113.9%
Total 13F principal
$72,983,000
Principal change
+$6,159,000
Total reported market value
$97,741,063
Number of holders
16
Value change
+$22,933,662
Number of buys
8
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 30050BAB7?
CUSIP 30050BAB7 identifies 30050BAB7 - EVOLENT HEALTH INC - NOTE 2.000%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOLENT HEALTH INC - NOTE 2.000%12/0 as of Q2 2018

As of 30 Jun 2018, EVOLENT HEALTH INC - NOTE 2.000%12/0 was held by 16 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $72,983,000 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, CITADEL ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, Verition Fund Management LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, and DEUTSCHE BANK AG\. This page lists 16 institutional bondholders reporting positions for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.